📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Repair of acute respiratory distress syndrome by stromal cell administration (REALIST): a structured study protocol for an open-label dose-escalation phase 1 trial followed by a randomised, triple-blind, allocation concealed, placebo-controlled phase 2 trial. (2022)

First Author: Gorman E

Attributed to: A GMP cell therapy facility to test cell based therapies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13063-022-06220-0

PubMed Identifier: 35562778

Publication URI: http://europepmc.org/abstract/MED/35562778

Type: Journal Article/Review

Volume: 23

Parent Publication: Trials

Issue: 1

ISSN: 1745-6215